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Objective: This study aimed to compare the quality of life (QoL) in patients with type 2
diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran.
Patients and Methods: In this cross-sectional study, 1847 patients with type 2 diabetes
were recruited from rural health-care centers affiliated to Neyshabur County (Iran) in 2012.
In addition to demographic information, two questionnaires WHOQoL-BREF and SF-36
questionnaires were used for data collection. Cronbach’s alpha coefficient was used for scale
reliability. We conducted an exploratory factor analysis for the investigation of construct
validity. Convergent and discriminant validity were analyzed using Spearman correlation
coefficient. To determine the relationships between the eight domains of SF-36 and four
domains of the WHOQoL-BREF, structural equation modelling was performed.
Results: Cronbach’s alpha coefficients were acceptable for all domains of both WHOQoL-
BREF (0.69–0.86) and SF-36 (0.63 −0.92) questionnaires. The principal component analysis
showed two separate factors: one for all domains of SF-36 and another for all domains of
WHOQoL-BREF. Spearman correlation coefficients of both instruments were partly to
strongly correlated with most domains (r ≥0.40). Correlations for domains with similar
constructs were stronger than those measuring varied constructs. Structural equation model-
ling recommended approximately moderate relationships among the SF-36 and WHOQoL-
BREF domains.
Conclusion: Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments
for clinical and research uses, respectably. However, results of the goodness of fit showed
that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered
more suitable for the study population.
Keywords: quality of life, type 2 diabetes, WHOQoL-BREF, SF-36, Iran
Introduction
Diabetes is a complex metabolic disorder which is determined by hyperglycemia.
Hyperglycemia is caused by impaired insulin secretion or function.1 Studies show
that more than 3 million people have diabetes in Iran. If effective preventive and
control measures are not done in this area, it will reach about 7 million people by
2030. Diabetes and its potential complications often lead to high financial costs,
reduced quality of life (QoL), and undesirable changes in lifestyle for the patient
and his or her family.2 Diabetic patients have many physical-psychological pro-
blems such as depression, anxiety, disability, inactivity and obesity that ultimately
can be lead to a significant decrease in QoL.3,4
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Findings of 20 years of Iranian study revealed an
annual crude incidence rate of 10 per 1000 person-year
of follow up for type 2 diabetes.5 A trend analysis showed
a 35.1% increase in diabetes mellitus prevalence from
2005 to 2011 in Iran.6 Besides, the economic burden of
diabetes mellitus in Iran is predicted to increase markedly
in the future decades.7
According to the WHO, QoL is defined as an indivi-
dual’s perception of their position in life in the context of
the culture and value systems in which they live and in
relation to their goals, expectations, standards and
concerns.8 In recent years, different studies have investi-
gated the QoL of patients with diabetes in Iran and have
shown that diabetic patients have a lower QoL than non-
diabetic patients,9–11 because the diabetes has a profound
effect on the QoL of diabetic patients due to physical
complications such as retinopathy, nephropathy, neuropa-
thy, cardiovascular disease and mental disorders.12 Also,
our knowledge shows that most studies in the field have
used the Short-Form 36 (SF-36) to assess the QoL of
patients with diabetes in Iran. However, some studies
have also used the Iranian version of the WHO QoL
Questionnaire (WHOQoL-BREF) to investigate the QoL
in these patients. But, studies that have simultaneously
measured and compared QoL in patients with diabetes
using these two questionnaires are very limited, especially
in Iran. Regarding the above description, the present study
was designed and implemented to compare the QoL in
patients with type 2 diabetes using two WHOQoL-BREF
and SF-36 questionnaires in Iran. The hypothesis of this
study was that both questionnaires (WHOQoL-BREF and




In our cross-sectional study, 1847 out of the 2224 patients
with type 2 diabetes participated in the study and com-
pleted the questionnaires. Patients were recruited from
rural health-care centers affiliated to Neyshabur
University of Medical Sciences (Neyshabur is a city in
north-east of Iran) between April and July 2012.
Participants were enrolled based on the accessible list in
the rural health care centers of Neyshabur. Subjects who
(a) had been definitely diagnosed with diabetes type 2, (b)
had no coexisting chronic debilitating disease (i.e., stroke,
or epilepsy), (c) had no audio-visual or psychological
problems, (d) dwelled in Neyshabur rural regions, and
(e) accepted to participate in the study. The patients were
diagnosed through diabetes screening programs based on
fasting blood sugar level. If fasting blood sugar level was
126 mg/dl or higher on two separate tests, the person
detected as a patient with diabetes. To make sure that
subjects were not suffering from other chronic diseases
or psychological and audio-visual impairments, we asked
them some questions and also we reviewed their health
records (available in health care centers). Patients (N=377)
with communication difficulties and lack of interest in
participating in the study were excluded.
Measures
To collect data, a three-section scale was applied including
a Demographic Data Form (containing of items related to
the patients’ sociodemographic characteristics—i.e., age,
gender, education level, marital status, household income,
BMI, and distance from the city), the Iranian validated
versions of World Health Organization Quality of Life
questionnaire (WHOQoL-BREF),13 and the Short-Form
36 (SF-36).14
All of three scales were responded by the patients in
a single session, first the socio-demographic characteris-
tics, then the WHOQoL-BREF, and finally the SF-36.
When requested to help, the investigator was limited to re-
reading the items slowly. The evaluation was managed by
interviewer whenever a patient had problem in understand-
ing the items.
SF-36 Quality of Life Questionnaire
The SF-36 is one of the most generally used HRQoL scale
in the world that has been widely validated in different
languages. It is a multicultural scale consisting of 36
questions and categorized into eight-domain profile of
scores: physical functioning (PF; 10 items), general health
(GH; 5 items), role physical (i.e., role limitations due to
the physical health problems, RP; 4 items), bodily pain
(BP; 2 items), social functioning (SF; 2 items), vitality
(VT; 4 items), role emotional (i.e., role limitations due to
emotional problems, RE; 3 items), and mental health (MH;
5 items).15 For each domain, a score ranging from 0 to 100
was assessed with a higher score indicating better health.
For the Iranian version of the SF-36, acceptable internal
consistency (Cronbach’s alpha coefficients were greater
from 0.77 to 0.90) and construct validities (discriminant
and convergent validities) have been reported above 0.40
ranging from 0.58 to 0.95.14
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WHOQoL-BREF Quality of Life Scale
The WHOQoL-100 is a multidimensional scale developed
for applying with a wide range of psychological and physi-
cal disorders. The WHOQoL Group initially generated
a WHOQoL scale with a 100-question form that allowed
a comprehensive estimation of 24 aspects about quality of
life. Having said that, the long content of questionnaire made
it difficult for researchers to assess only the HRQoL.
Consequently, two questions from the total health and gen-
eral QoL and one question from each of the remaining
twenty-four aspects were chosen to form the WHOQoL-
BREF.16 These aspects are classified into four domains:
Physical health (PH; 7 items), psychological well-being
(PS; 6 items), social relationships (SR; 3 items) and envir-
onment health (EH; 8 items). All questions are rated on
a 5-point Likert scale, and the item is scored between 1
and 5. Raw scores in each domain were changed to a 4–20
score based on the guideline. All domain scores were line-
arly changed such that they varied from 0 to 100 with “100”
demonstrating the highest possible QoL. The Iranian version
of the WHOQoL-BREF was validated in compliance with
WHO guidelines.17 Additionally, comprising 26-question
translated from the original WHOQoL-BREF questionnaire,
the Iranian version contains two added questions of local
importance, i.e., Being Valued and Food Availability.18
Good reliabilities (including an internal consistency of 0.-
76–0.82 and a test-retest reliability of 0.76–0.82) and valid-
ities of the Iranian version have been founded.19 To use all
information in the WHOQoL-BREF, the Overall Health and
General QoL aspect also were assessed as a single score as
with the scoring method for the other domain scores,




Exploratory factor analysis was performed to test construct
validity, using a principal component analysis with vari-
max rotation approach for the 12 separate domains (4
domains from the WHOQoL-BREF and 8 domains from
the SF-36). Eigenvalues greater than 1 (˃1) and scree plot
were performed to determine the number of quality of life
factors extracted. Factor loadings equal to or more than 0.4
were determined suitable.20
Reliability
Internal consistency of the domains was assessed by the
Cronbach’s alpha coefficient for the entire scales, each
construct, and each factor. The Cronbach’s alpha coeffi-
cient of 0.7 or above was determined acceptable.21
Convergent & Discriminant Validity
To evaluate the convergence and discriminant validity,
correlations among the SF-36 and the WHOQoL-BREF
were examined applying Spearman correlation coefficient.
It was hypothesized that those domains that are concep-
tually related would be more strongly correlated, but those
domains in the two instruments with less in common
would demonstrate weaker correlations.
Therefore, we assumed moderate to high correlations
(r≥0.4) between all domains of the WHOQoL-BREF and
all domains of the SF-36; the Overall QoL and GH of the
WHOQoL-BREF and the GH of the SF-36; the PF, RP,
and BP domains of the SF-36 with consisting domain the
PH of the WHOQoL-BREF; the SF, RE, and MH domains
of the SF-36 with consisting domains and the PS and SR
of the WHOQoL-BREF.
Confirmatory Factor Analysis
To examine the relationships between the eight domains of
SF-36 and four domains of the WHOQoL-BREF, struc-
tural equation modeling was performed. It was tested the
extent to which the variance in each domain was explained
by other domains in both instruments. We used the incre-
mental fit index (IFI), the comparative fit index (CFI), the
Tucker–Lewis Index (TLI), the root-mean-square error of
approximation (RMSEA), and the Akaike’s information
criterion (AIC) in order to assess model fit. AMOS soft-
ware version 23 was used for structural equation modeling
and p<0.05 was considered as statistically significant.
Ethical Considerations
This study was approved by the Ethical Committee of Iran
university of medical sciences approved the study (Ethical
code: IR.IUMS.REC 1394.94–02-193-26156). Permission
to conduct the study was obtained from this committee and
the study was conducted in accordance with the
Declaration of Helsinki. A verbal informed consent form




1847 out of all 2224 patients with type 2 diabetes were
included in the study. There were 1289 female (69.8%)
and 558 male (30.2%) patients in the study group. The
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mean ± SD age was 59.65 ± 12.3 years, and the age
range was 30–97 years. Of the patients, 19.9% were
married, 66.2% were Illiterate, and household salary of
86.9% of patients was less than 200$ per months
(Table 1).
Score distributions of both the SF-36 and the
WHOQoL-BREF are presented in Table 2. Of all the
subscales, SF achieved the highest value for SF-36 and
SR for WHOQoL-BREF. The lowest was GH for SF-36
and PS for WHOQoL-BREF.
Scale Reliability
The internal consistency of all domains is presented on the
diagonal of Table 2. Cronbach’s alpha coefficients for SF-
36 subscales ranged from 0.63 (SF) to 0.92 (PF), and from
0.69 (SR) to 0.86 (PH) for the WHOQoL-BREF showing
good internal consistency between these specific items
within each domain.
Construct Validity
It was applied iterated principal component analysis with
oblique rotation to specify the structure of all of the
domains for the SF-36 and WHOQoL-BREF. It was
found two separate factors with eigenvalues more than
1.0 (Table 3). However, the scree plot revealed a three-
factor solution. Furthermore, the first and second factors
accounted for 50.9% and 10.4% of the variance in all
domains. The proper level for a factor was considered
acceptable when they loaded equal or greater than 0.40.
The first factor extracted included all domains of the SF-
36, and the second factor extracted included all domains of
the WHOQoL-BREF.
Convergent and Discriminant Validity
In Spearman correlation coefficients of the SF-36, domains
assessing similar constructs were partly to moderately
correlated (r=0.40–0.60), while domains assessing varied






<60 yr 922 50
≥ 60 yr 921 50
Education Level*
Illiterate 1203 66.2




Household Income (per month)*
<200 $ 1272 86.9
≥200 $ 192 13.1
Note: *Some data were missing (4 data in age and 31 data in education level).
Table 2 Score Distributions of the Instruments SF-36 and WHOQoL-100
Subscales Mean SD Median Minimum Score Maximum
Score
Lower Quartile Upper Quartile Cronbach’s α
SF-36
PF 54.99 28.50 55 0 100 35 75 0.92
RP 46.63 42.92 50 0 100 0 100 0.88
BP 54.43 23.23 55 0 100 45 67.50 0.83
GH 39.89 18.13 40 0 100 30 50 0.76
VT 54.94 17.71 56 0 100 35 60 0.73
SF 62.18 21.02 62.5 0 100 50 75 0.63
RE 50.37 44.90 33.33 0 100 0 100 0.88
MH 47.87 18.76 50 0 100 44 68 0.77
WHOQoL-BREF
PH 49.33 16.79 50 0 100 38 63 0.86
PS 48.39 15.58 50 0 100 44 56 0.78
SR 54.16 18.39 56 0 100 44 69 0.69
EH 52.89 13.73 56 0 100 44 63 0.76
Abbreviations: SF-36, Short Form 36 Health Survey; WHOQoL-BREF, World Health Organization Quality of Life Scale Brief Version; SD, standard deviation; PF, physical
functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health. PH, physical health; PS,
psychological well-being; SR, social relationships; EH, environment health.
Abbasi-Ghahramanloo et al Dovepress
submit your manuscript | www.dovepress.com
DovePress






































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
constructs were weakly correlated (r < 0.40). For example,
the correlation between PF and RP was 0.49, but the
correlation of PF and MH was 0.37. Correlations between
the WHOQoL-BREF domains were reasonable. For
domains that assess like concepts in both the SF-36 and
WHOQoL-BREF, the PF, SF, and MH domains of the SF-
36 were moderately correlated (r=0.40–0.60) with the cor-
responding PH and SR domains of the WHOQoL-BREF
(Table 4). For instance, the correlation between the SF-36
PF domain and the WHOQoL-BREF PH domain was
0.55; the association of the SF-36 MH domain and the
WHOQoL-BREF PS domain was 0.6. Domains in the SF-
36 and WHOQoL-BREF that did not match to one another
were similarly associated (Table 4). For instance, the asso-
ciation of the SF-36 PF domain and the WHOQoL-BREF
PS domain was 0.37.
Relations Among Domains of Both SF-36
and WHOQoL-BREF
The eight domains of SF-36 and four domains of
WHOQoL-BREF were also subjected to the confirmatory
factor analysis to test the fitness of a model. This model
fits the relationships among all domains of the SF-36 and
WHOQoL-BREF good. Covariance matrixes were applied
and fit indexes were calculated. The relative chi-square
(χ2) for models 1, 2, and 3 was equal to 24.29, 7.23,
263.16, respectively, and showing the goodness of fit for
the model (P<0.05). The RMSEA of model 1 was 0.028
presenting good fit. Additionally, the RMSEA for models
2 and 3 was 0.058 and 0.06, respectively. All comparative
indices of the 3-model including CFI, IFI, and TLI were
more than 0.90 (0.998, 0.998, and 0.994 for model 1,
0.998, 0.998, and 0.988 for model 2, and 0.981, 0.981,
and 0.964 for model 3, respectively) of which fall in the
acceptable range. The AIC for models 1, 2, and 3 were
72.0, 20.0 and 156.0, respectively, showing adequate fit for
three models (Table 5). The results obtained from the CFA
are shown in Figures 1 and 2 and Table 5. Comparing
Figures 1 and 2 showed that weights of subscales were not
statistically different with weights in separate models
(P-value=0.507).
Discussion
In this population from Iran (Neyshabur) patients with
type 2 diabetes, the SF-36 and WHOQoL-BREF question-
naires appeared to measure distinct concepts related to
QoL. In our study sample, about 90% of patients’ house-
hold income was lower than 200$ per month and that was
approximately approved with sex ratio and education level
ratio. It is discovered that social subscales are high with
two instruments. It can be argued that the questions of the
two subscales are very similar; SF has 2 items and SR
have 3 items. The exploratory factor analysis approxi-
mately extracted two distinct factors influencing QoL –
one factor was associated with all subscales of the SF-36
and the other one associated with all subscales of the
WHOQoL-BREF. Our results are consistent with a study
carried out by Huang et al.22 In the multitrait analysis,
correlations were approximately similar among subscales
hypothesized to measure homogenous constructs and het-
erogeneous subscales. Our results suggested that the ques-
tionnaires related domains approximately provided similar
measures in evaluating Iranian (Neyshabur) patients with
type 2 diabetes and Structural equation modelling sug-
gested approximately moderate relationships among
domains of the SF-36 and WHOQoL-BREF. The correla-
tion between the SF-36 and the WHOQoL-BREF has been
examined in some studies and in different fields. In
a national survey on 11,440 people, Huang et al indicated
that the correlations were weak among the subscales of
both instruments and concluded that both SF-36 and
Table 3 Exploratory Factor Analysisa of the SF-36 and
WHOQoL-BREF
Subscales Factor Loading b H2c
Factor I Factor II
SF-36
PF 0.683 0.210 0.510
RP 0.803 0.057 0.649
BP 0.737 0.264 0.613
GH 0.635 0.435 0.593
VT 0.593 0.563 0.669
SF 0.523 0.383 0.420
RE 0.713 0.168 0.536
MH 0.593 0.497 0.599
WHOQoL-BREF
PH 0.583 0.637 0.746
PS 0.320 0.808 0.756
SR 0.139 0.736 0.561
EH 0.092 0.829 0.695
Notes: aUsing iterated principal factor analysis with eigenvalue >1.0. bAfter oblique
rotation. cCommunality: proportion of a variable’s variance explained by a factor
structure.
Abbreviations: SF-36, Short Form 36 Health Survey; WHOQoL-BREF, World
Health Organization Quality of Life Scale Brief Version; PF, physical functioning;
RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social function-
ing; RE, role emotional; MH, mental health. PH, physical health; PS, psychological
well-being; SR, social relationships; EH, environment health.
Dovepress Abbasi-Ghahramanloo et al
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WHOQoL-BREF appeared to measure different con-
structs. To put it another way, the SF-36 measured health-
related QoL, while the WHOQoL-BREF measured global
QoL.22 However, in another study by Hsiung et al on
patients with HIV infection, both the WHOQoL-BREF
and the SF-36 were reliable and valid health-related QoL
instruments.23 In the present study, we found moderate
correlations across the subscales of the two questionnaires
among type 2 diabetes patients. It appears that the relia-
bility and validity of these two questionnaires for the
evaluation of QoL in patients with variant diseases may
be different. Transversal studies have shown that the SF-
36 is a valid and reliable instrument for detecting differ-
ences between groups defined by age, sex, socio-economic
status, and clinical condition.24 Also, in a study among the
Iranian population, the Persian version of the SF-36 per-
formed well and the findings suggested that it was
a reliable and valid measure of QoL among the general
populations.14 Therefore, it can be concluded that SF-36 is
an applicable tool for the evaluation of QoL in patients
with type 2 diabetes. The correlations between the
WHOQoL-BREF and the SF-36 were as expected in
most items. A correlation higher than 0.45 was found
between the physical domain of the WHOQoL-BREF
and emotional role, vitality, mental health and social
Table 4 Correlation Coefficients Between the SF-36 and WHOQoL-BREF Domains
PF RP RE VT MH SF BP GH PH PS SR EH
PF CC 1 0.49 0.40 0.46 0.37 0.36 0.50 0.48 0.55 0.37 0.31 0.3
Sig <0.001 0.005 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
RP CC 1 0.65 0.41 0.36 0.33 0.49 0.43 0.48 0.35 0.27 0.25
Sig <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
RE CC 1 0.45 0.43 0.37 0.41 0.39 0.45 0.40 0.31 0.30
Sig <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
VT CC 1 0.74 0.48 0.55 0.68 0.66 0.59 0.41 0.43
Sig <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
MH CC 1 0.52 0.48 0.56 0.57 0.60 0.41 0.42
Sig <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
SF CC 1 0.50 0.40 0.49 0.44 0.32 0.30
Sig <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
BP CC 1 0.58 0.62 0.43 0.29 0.28
Sig <0.001 <0.001 <0.001 <0.001 <0.001
GH CC 1 0.67 0.51 0.34 0.36
Sig <0.001 <0.001 <0.001 <0.001
PH CC 1 0.70 0.49 0.56
Sig <0.001 <0.001 <0.001
PS CC 1 0.53 0.67
Sig <0.001 <0.001




Abbreviations: SF-36, Short Form 36 Health Survey; WHOQoL-BREF, World Health Organization Quality of Life Scale Brief Version; PF, physical functioning; RP, role
physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health. PH, physical health; PS, psychological well-being; SR,
social relationships; EH, environment health; CC, correlation coefficients; Sig, significant. (2-tailed).
Table 5 Three Used Models and the Fitness of a Models
Measure Model
1 2 3
χ2 24.29 7.23 263.16
df 10 1 34
P-value 0.007 0.007 <0.001
CFI 0.998 0.998 0.981
IFI 0.998 0.998 0.981
TLI 0.994 0.988 0.964
RMSEA 0.028 0.058 0.06
AIC 72.0 20.0 156.0
Notes: Model 1 construct of SF-36; Model 2 construct of WHOQoL- BREF; Model
3 correlated methods (i.e., SF-36 and WHOQoL-BREF). Acceptable fit indices are
in bold.
Abbreviations: χ2, chi-square; df, degree of freedom; IFI, incremental fit index;
CFI, comparative fit index; TLI, Tucker–Lewis Index; RMSEA, root-mean-square
error of approximation; SRMR, standardized root-mean-square residual; AIC,
Akaike’s information criterion; SF-36, Short Form 36 Health Survey; WHOQoL-
BREF, World Health Organization Quality of Life Scale Brief Version.
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functioning subscales from the SF-36 that were more than
the expected size. This can be attributed to overlapping
domains in the WHOQoL-BREF.25,26 Bonomi et al26
reported that physical health subscales (PF, RP, BP, and
GH) of the SF-36 were moderately correlated (r: 0.6–0.4)
with both physical and psychological subscales of the
WHOQoL-BREF. In our study, some mental subscales
(VT and MH) of the SF-36 were highly correlated
(r>0.6) with both physical and psychological subscales of
the WHOQoL-BREF, and some mental subscales (SF and
RE) were moderately correlated with both physical and
psychological WHOQoL-BREF subscales. Norholm27
and Skevington28 reported that physical subscales of the
SF-36 were more strongly correlated with physical than
Figure 1 (A) Model 1: Confirmatory factor analysis (CFA) for the eight domains of the SF-36. (B) Model 2: Confirmatory factor analysis (CFA) for the four domains of the
WHOQoL-BREF (n = 1847).
Abbreviations: SF-36, Short Form 36 Health Survey; WHOQoL-BREF, World Health Organization Quality of Life Scale Brief Version; PF, Physical Functioning; GH, General
Health; RP, Role Physical; BP, Bodily Pain; SF, Social Functioning; VT, Vitality; RE, Role Emotional; MH, Mental Health. PH, Physical Health; PS, Psychological well-being; SR,
Social Relationships; EH, Environment Health.
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psychological subscales of the WHOQoL-BREF.
Furthermore, it is likely that SF-36 is a more objective
measure, because its questions are about capability and
disability, whereas WHOQoL-BREF focuses on individual
opinions about QoL and so the SF-36 questions are more
objective in comparison to the completely subjective ques-
tions of the WHOQoL-BREF. However, evidence suggests
that these tools do not measure exactly the same con-
structs. The evidence suggests that WHOQoL-BREF is
more sensitive to the demographic characteristics of
participants.22,29 The literature indicates that these instru-
ments have a weak convergent validity for healthy
populations22,30 and high magnitude correlation for studies
with patient groups.23,31 The observed divergences may be
a consequence of differences in the goals adopted by
developers of the instruments. SF-36 measures aspects
that are linked to health and functional performance of
individuals, whereas WHOQoL-BREF instruments
attempt to measure a broad range of factors concerning
the organism, task, and environment.32,33
In construct validity, we also used correlations of SF-
36 and WHOQoL-BREF and results showed that weights
of subscales were not statistically different with weights in
separate models. However, in some subscales (especially
in WHOQoL-BREF subscales) there were seen more than
15% changes.
We also compared the goodness of fit of three models
with different indexes. We found that approximately all
three models were fitted well and similarly. But according
to AIC index, model 2 was fitted well. Both scales repre-
sented acceptable reliability in this study. The study find-
ings indicated satisfactory alpha coefficients in all domains
except for the SF and SR. This can be attributed to the
small number of questions (2 items in SF-36 and 3 items
Figure 2 Model 3: Confirmatory factor analysis (CFA) for the eight domains of the SF-36 in correlation to four domains of the WHOQoL-BREF (n = 1847).
Abbreviations: SF-36, Short Form 36 Health Survey; WHOQoL-BREF, World Health Organization Quality of Life Scale Brief Version; PF, Physical Functioning; GH, General
Health; RP, Role Physical; BP, Bodily Pain; SF, Social Functioning; VT, Vitality; RE, Role Emotional; MH, Mental Health. PH, Physical Health; PS, Psychological well-being; SR,
Social Relationships; EH, Environment Health.
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in WHOQoL-BREF) in their domains. In addition, these
domains do not appear very homogenous at least in the
Iranian culture, since they inquire about sexual life and
social supports that are relatively different concepts in
Iranian culture. Other studies conducted upon different
populations showed similar results concerning
reliability.22,23,30,31,34-36 It is important to make sure that
the results can be generalized to evaluate a particular
patient, because the statistical analyses of these studies
are based on large samples and do not consider individual
differences.
There are some explanations for differences between
these two questionnaires. First, SF-36 discriminates better
among different levels of health status and utilization than
the WHOQoL-BREF. As a result, it may be appropriate to
describe the SF-36 as a measure of health-related QoL that
focus mainly on health-related functioning and perceptions.
Second, same subscales of the two instruments may mea-
sure different concepts of perceived QoL. In other words,
the SF-36 may measure objective QoL. However, the
WHOQoL-BREF may measure self-reported subjective
QoL.22
However, some limitations should be mentioned. First,
the generalizability of our findings may be limited because
all patients in this study were recruited from rural regions.
The study was unable to enroll representative patients with
diabetes in urban regions. Second, cross-sectional design
was used in this study. Prospective studies are needed to
specify the responsiveness of studied instruments based on
changes in the clinical status of patients with diabetes.
In conclusion, this study suggests that SF-36 and
WHOQoL-BREF are reliable for clinical and research
uses. But according to the goodness of fit results, the
WHOQoL-BREF showed a better fit. Moreover, the
WHOQoL-BREF can be considered more suitable for
this study population because it valued age in individuals’
personal opinions. Nevertheless, to select one, researchers
should consider which aspects of QoL they aim to capture,
because of the observed weak convergent validity signs.
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